Phase III Clinical Research — Fall River, Massachusetts

Phase III Clinical Research is a clinical research site located in Fall River, Massachusetts, United States 02720.

Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

Phase III Clinical Research has participated in 13 clinical trials.

Therapeutic areas: Rheumatoid Arthritis, Obesity, Diabetes Mellitus, Non-Insulin-Dependent.

Sponsors: Pfizer, Ronald J. Rapoport, MD, Sanofi.

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Phase III Clinical Research?

Phase III Clinical Research has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Phase III Clinical Research conducted?

Phase III Clinical Research has 13 clinical trials on record. Their work covers Rheumatoid Arthritis, Obesity, Diabetes Mellitus, Non-Insulin-Dependent.

Is Phase III Clinical Research accredited by Crixeo Health?

Yes — Phase III Clinical Research holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Phase III Clinical Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.